Log in to save to my catalogue

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4594674

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity

About this item

Full title

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity

Author / Creator

Publisher

England: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2015-10, Vol.19 (10), p.2324-2328

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Doxorubicin is the mainstay of treatment for various haematological malignancies and solid tumours. However, its clinical application may be hampered by dose‐dependent cardiotoxicity. The mechanism of doxorubicin‐induced cardiotoxicity may involve various signalling pathways including free radical generation, peroxynitrite formation, calcium overlo...

Alternative Titles

Full title

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin‐induced cardiotoxicity

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4594674

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4594674

Other Identifiers

ISSN

1582-1838

E-ISSN

1582-4934

DOI

10.1111/jcmm.12633

How to access this item